[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334927-105":59,"doc-detail-334927-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","faecalibaterium-prausnitzii-strain-exl01-boosts-efficacy-of-immune-checkpoint-inhibitors-original-research","Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors - Original Research","","Gut microbiota influences responses to immune checkpoint inhibitors (ICI). Elevated Faecalibacterium prausnitzii has been linked to favorable ICI outcomes across cancer types. Using fecal shotgun metagenomics, the study reports that baseline high F. prausnitzii in non-small cell lung cancer and advanced melanoma cohorts correlates with improved clinical response. In MCA205 tumor-bearing mice, EXL01 restores anti-tumor activity of ICI despite antibiotic-induced microbiota disruption, and strengthens T cell activation in vitro. Oral EXL01 shows no fecal diversity shift, suggesting a direct small-intestine immune effect.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/faecalibaterium-prausnitzii-strain-exl01-boosts-efficacy-of-immune-checkpoint-inhibitors-original-research/334927/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/faecalibaterium-prausnitzii-strain-exl01-boosts-efficacy-of-immune-checkpoint-inhibitors-original-research/334927.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What baseline microbiota feature is associated with better ICI response in this study?","Question",{"text":113,"@type":114},"A high baseline level of Faecalibacterium prausnitzii is positively associated with improved clinical response to ICI.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does Faecalibacterium prausnitzii strain EXL01 affect ICI efficacy in mice?",{"text":118,"@type":114},"In MCA205 tumor-bearing mice, EXL01 restores the anti-tumor response to ICI under antibiotic-induced microbiota perturbation at both clinical and tumor transcriptomic levels.",{"name":120,"@type":111,"acceptedAnswer":121},"Why does the study suggest a direct immune effect in the small intestine?",{"text":122,"@type":114},"Oral EXL01 does not change fecal microbiota diversity or composition, implying a direct effect on immune cells in the small intestine.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},334927,1790296079,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":4},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","ONCOIMMUNOLOGY  \n2024, VOL. 13, NO. 1, 2374954 [https://doi.org/10.1080/2162402X.2024.2374954](https://doi.org/10.1080/2162402X.2024.2374954)  \nORIGINAL RESEARCH     \nFaecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors  \nMarius Bredona,b*, Camille Dannea,b*, Hang Phuong Phamc, Pauline Ruffiéd, Alban Bessedee, Nathalie Rolhiona,b, Laura Creusota,b, Loic Brota,b, Iria Alonsoa,b, Philippe Langellaf, Lisa Derosag,h,i, Alexis B. Cortotj, Bertrand Routyk,l, Laurence Zitvogelg,h,i,m, Nicola Segatan,o, and Harry Sokol a,b,f  \naGastroenterology Department, Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Saint-Antoine Hospital, Paris, France; bParis Center for Microbiome Medicine (PaCeMM) FHU, Paris, France; cParean Biotechnologies, Saint-Malo, France; dExeliom Biosciences, Dijon, France; eExplicyte Immuno-Oncology, Bordeaux, France; fMicalis Institute, Université Paris-Saclay, INRAE, AgroParisTech, Jouy-en-Josas, France; gUMR1015 Gustave Roussy Cancer Campus, Villejuif, France; hDépartement de Médecine Oncologique, Gustave Roussy Cancer Campus, Villejuif, France; iFaculté de Médecine, Université Paris-Saclay, Le Kremlin-Bicetre, France; jUniversité de Lille, CHU Lille, Thoracic Oncology Department, Centre National de la Recherche Scientifique, INSERM, Institut Pasteur de Lille, UMR9020-UMR-S 1277-Canther, Lille, France; kDepartment of Medicine, HematologyOncology Division, University of Montreal Healthcare Centre (CHUM), Montreal, QC, Canada; lUniversity of Montreal Research Center (CRCHUM), Montreal, QC, Canada; mCenter of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, France; n Department CIBIO, University of Trento, Trento, Italy; oIEO, European Institute of Oncology IRCCS, Milan, Italy  \nABSTRACT  \nGut microbiota impacts responses to immune checkpoint inhibitors (ICI) . A high level of Faecalibacterium prausnitzii have been associated with a positive response to ICI in multiple cancer types. Here, based on fecal shotgun metagenomics data, we show in two independent cohorts of patients with non-small cell lung cancer and advanced melanoma that a high level of F. prausnitzii at baseline is positively associated with a better clinical response to ICI. In MCA205 tumor-bearing mice, administration of F. prausnitzii strain EXL01, already in clinical development for Inflammatory Bowel Disease, restores the anti-tumor response to ICI in the context of antibiotic-induced microbiota perturbation at clinical and tumor transcriptomics level. In vitro, EXL01 strain enhances T cell activation in the presence of ICI. Interestingly, oral administration of EXL01 strain did not induce any change in fecal microbiota diversity or composition, suggesting a direct effect on immune cells in the small intestine. F. prausnitzii strain EXL01 will be evaluated as anadjuvant to ICI in multiple cancers in the near future.  \nARTICLE HISTORY  \nReceived 27 March 2024 Revised 26 June 2024 Accepted 27 June 2024  \nKEYWORDS  \nCancer; gut microbiota; immune checkpoint inhibitor  \nIntroduction  \nImmunotherapy has revolutionized the oncology landscape by releasing the “breaks” on patient’s T cells. Immune checkpoint inhibitors (ICI) such as antibodies targeting CTLA-4, PD-1 and its ligand (PD-L1), are proven effective in several solid and hematologic cancers. 1 The gut microbiota plays a key role in shaping the immune response, and is a major tumorextrinsic regulator of responses to immunotherapy. Early studies reported that antibiotics (ABX) impair the therapeutic effect of ICI (anti-PD-1 alone or combined with anti-CTLA-4 antibodies) in sarcoma and melanoma-bearing mice with increased tumor size and reduced overall survival (OS) .2 In humans, early ABX exposure (prior to or early during ICI therapy) has been associated with decreased immunotherapy efficacy in multiple cancers types.2,3 Logically, the next step was to identify gut microbiota features at baseline associated with res","cbCaiu4Em2NYN6vq","https://ap.wps.com/l/cbCaiu4Em2NYN6vq","pdf",3397404,12,"English","# Abstract\n# Introduction\n## Immune checkpoint inhibitors and gut microbiota\n## Prior evidence linking antibiotics and microbiota features to ICI outcomes","[{\"question\":\"What baseline microbiota feature is associated with better ICI response in this study?\",\"answer\":\"A high baseline level of Faecalibacterium prausnitzii is positively associated with improved clinical response to ICI.\"},{\"question\":\"How does Faecalibacterium prausnitzii strain EXL01 affect ICI efficacy in mice?\",\"answer\":\"In MCA205 tumor-bearing mice, EXL01 restores the anti-tumor response to ICI under antibiotic-induced microbiota perturbation at both clinical and tumor transcriptomic levels.\"},{\"question\":\"Why does the study suggest a direct immune effect in the small intestine?\",\"answer\":\"Oral EXL01 does not change fecal microbiota diversity or composition, implying a direct effect on immune cells in the small intestine.\"}]","Faecalibaterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors - Original Research | PDF",1790008869]